Methods and compositions for treating ophthalmic conditions with retinyl derivatives

Details for Australian Patent Application No. 2005262558 (hide)

Owner Sirion Therapeutics, Inc.

Inventors Mata, Nathan L.; Widder, Kenneth; Lichter, Jay

Agent Griffith Hack

Pub. Number AU-B-2005262558

PCT Pub. Number WO2006/007314

Priority 60/660,904 11.03.05 US; 60/672,405 18.04.05 US; 60/582,293 23.06.04 US; 60/629,695 19.11.04 US

Filing date 6 June 2005

Wipo publication date 19 January 2006

Acceptance publication date 20 March 2008

International Classifications

A61K 31/167 (2006.01) - having the nitrogen atom of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol

A61P 27/02 (2006.01) Drugs for disorders of the senses

Event Publications

4 January 2007 PCT application entered the National Phase

  PCT publication WO2006/007314 Priority application(s): WO2006/007314

20 March 2008 Application Accepted

  Published as AU-B-2005262558

17 July 2008 Standard Patent Sealed

17 June 2010 Assignment Registered

  SIRiON Therapeutics, Inc. The patent has been assigned to ReVision Therapeutics, Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005262560-Power control using erasure techniques

2005262552-Educational toy